| 注册
首页|期刊导航|中国食品药品监管|新型结核病疫苗全球研发现状

新型结核病疫苗全球研发现状

熊玮仪 鲁爽

中国食品药品监管Issue(5):62-69,8.
✕
中国食品药品监管Issue(5):62-69,8.DOI:10.3969/j.issn.1673-5390.2026.05.004

新型结核病疫苗全球研发现状

Global Status of Research and Development for New Tuberculosis Vaccines

熊玮仪 1鲁爽1

作者信息

  • 1. 国家药品监督管理局药品审评中心
  • 折叠

摘要

Abstract

Tuberculosis(TB)remains a major infectious disease that seriously threatens public health worldwide.The development of new TB vaccines is of vital importance for the prevention and control of global TB.This article aims to provide an overview of the global status of progress in the research and development of new TB vaccines,with the goal of offering references for vaccine research and development efforts related works in China.

关键词

结核病/卡介苗/新型结核病疫苗/疫苗研发

Key words

tuberculosis/Bacillus Calmette-Guérin(BCG)vaccine/new TB vaccines/vaccine research and development

分类

医药卫生

引用本文复制引用

熊玮仪,鲁爽..新型结核病疫苗全球研发现状[J].中国食品药品监管,2026,(5):62-69,8.

中国食品药品监管

1673-5390

访问量0
|
下载量0
段落导航相关论文